XBIT — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.62

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.28

Target Price

Analyst Recom

Performance Q

-6.15

Upside

-945.9%

Beta

0.86

Ticker: XBIT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	XBIT	2.36	0.12	0.00	268
2026-03-10	XBIT	2.35	0.12	0.00	270
2026-03-11	XBIT	2.34	0.12	0.00	270
2026-03-12	XBIT	2.34	0.12	0.00	270
2026-03-13	XBIT	2.34	0.12	0.00	270
2026-03-17	XBIT	2.26	0.12	0.00	270
2026-03-18	XBIT	2.26	N/A	N/A	0
2026-03-19	XBIT	2.36	0.12	17.20	271
2026-03-20	XBIT	2.34	1.53	999.99	649
2026-03-23	XBIT	2.35	0.49	999.99	379
2026-03-24	XBIT	2.355	0.49	999.99	379
2026-03-25	XBIT	2.365	0.50	0.00	382
2026-03-26	XBIT	2.32	0.13	0.00	1103
2026-03-27	XBIT	2.27	0.13	999.99	1124
2026-03-30	XBIT	2.29	0.14	999.99	1134
2026-03-31	XBIT	2.38	0.14	24.00	1136
2026-04-01	XBIT	2.35	0.19	0.00	1186
2026-04-02	XBIT	2.3474	0.19	999.99	1188
2026-04-06	XBIT	2.32	0.19	999.99	1188
2026-04-07	XBIT	2.29	0.20	999.99	1199
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	XBIT	2.36	-	-	-
2026-03-10	XBIT	2.35	-	-	-
2026-03-11	XBIT	2.35	-	-	-
2026-03-12	XBIT	2.35	-	-	-
2026-03-13	XBIT	2.33	-	-	-
2026-03-17	XBIT	2.25	-	-	-
2026-03-18	XBIT	2.26	-	-	-
2026-03-19	XBIT	2.37	-	-	-
2026-03-20	XBIT	2.34	-	-	-
2026-03-23	XBIT	2.36	-	-	-
2026-03-24	XBIT	2.36	-	-	-
2026-03-25	XBIT	2.36	-	-	-
2026-03-26	XBIT	2.32	-	-	-
2026-03-27	XBIT	2.26	-	-	-
2026-03-30	XBIT	2.26	-	-	-
2026-03-31	XBIT	2.38	-	-	-
2026-04-01	XBIT	2.35	-	-	-
2026-04-02	XBIT	2.36	-	-	-
2026-04-06	XBIT	2.32	-	-	-
2026-04-07	XBIT	2.28	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	XBIT	0.00	-11.14	0.57
2026-03-10	XBIT	0.00	-11.14	0.57
2026-03-11	XBIT	0.00	-11.14	0.56
2026-03-12	XBIT	0.00	-11.14	0.56
2026-03-13	XBIT	0.00	-11.14	0.56
2026-03-17	XBIT	0.00	-11.14	0.56
2026-03-18	XBIT	0.00	-11.14	0.56
2026-03-19	XBIT	0.00	-11.14	0.56
2026-03-20	XBIT	0.00	-11.14	0.56
2026-03-23	XBIT	0.00	-11.14	0.56
2026-03-24	XBIT	0.00	-11.14	0.56
2026-03-25	XBIT	0.00	-11.14	0.62
2026-03-26	XBIT	0.00	-11.14	0.62
2026-03-27	XBIT	0.00	-11.14	0.62
2026-03-30	XBIT	0.00	-11.14	0.62
2026-03-31	XBIT	0.00	-11.14	0.62
2026-04-01	XBIT	0.00	-11.14	0.62
2026-04-02	XBIT	0.00	-11.14	0.62
2026-04-06	XBIT	0.00	-11.14	0.62
2026-04-07	XBIT	0.00	-11.14	0.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-11.14

Beta

0.86

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

87.7

Max Drawdown 5-Year %

-87.2

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.5

P/Free Cash Flow

EPS

-1.49

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.57

Return on Equity vs Sector %

-59.9

Return on Equity vs Industry %

-43.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ XBIT Healthcare

$2.29

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

9/25

Volume

11/15

Valuation

12/20

TP/AR

0/10

Options

7/10

RSI

44.4

Range 1M

43.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

0/30

Estimates

0/20

Inst/Vol

0/15

Options

5/10

EPS Yr

EPS NY

52W%

13.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +1122.7% upside

Quality

2/30

Valuation

16/30

Growth

0/25

Stability

6/10

LT Trend

4/5

Upside

+1122.7%

Quality

XBiotech Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 85

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

XBIT

Latest News

—

Caricamento notizie per XBIT…

stock quote shares XBIT – XBiotech Inc. Stock Price stock today

news today XBIT – XBiotech Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch XBIT – XBiotech Inc. yahoo finance google finance

stock history XBIT – XBiotech Inc. invest stock market

stock prices XBIT premarket after hours

ticker XBIT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: XBIT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y